States Offering Partial GLP-1 Coverage for Obesity: Another 22 states, including Texas, Arizona, and Washington, offer partial coverage for obesity-specific GLP-1s
Learning how metabolic medications function later can allow parents to plan in advance
The first month is a titration phase, not a weight loss phase
To date, these GLP-1 drugs have been approved to treat three adult populations: individuals with type 2 diabetes, individuals with a body mass index (BMI) of 30 or greater (obesity), and individuals with a BMI between 27 and 30 (overweight) with at least one weight-related health condition, such as cardiovascular disease, high blood pressure, high cholesterol, prior stroke, prior heart attack, and chest pain (angina)
Adams LC, Lbbe F, Bressem K, Wagner M, Hamm B, Makowski MR
Record every injection: date, time, dose, injection site, and any side effects